Cook Wealth’s GSK GSK Stock Holding History

Cook Wealth’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,322	Closed	-$400K	–	23
2025 Q1	$400K	Hold	10,322	–	–	0.19%	37
2024 Q4	$351K	Hold	10,322	–	–	0.16%	43
2024 Q3	$382K	Hold	10,322	–	–	0.19%	39
2024 Q2	$403K	Hold	10,322	–	–	0.22%	38
2024 Q1	$447K	Sell	10,322 -4,869	-32%	-$201K	0.27%	32
2023 Q4	$593K	Hold	15,191	–	–	0.38%	27
2023 Q3	$542K	Sell	15,191 -2,348	-13%	-$83.3K	0.42%	21
2023 Q2	$629K	Sell	17,539 -5,822	-25%	-$209K	0.48%	19
2023 Q1	$841K	Buy	23,361 +23	+0.1%	+$805	0.72%	11
2022 Q4	$820K	Hold	23,338	–	–	0.79%	9
2022 Q3	$764K	Buy	23,338 +4,668	+25%	+$177K	0.83%	11
2022 Q2	$941K	Sell	18,670 -15,339	-45%	-$847K	0.97%	8
2022 Q1	$1.59M	Buy	34,009 +10,671	+46%	+$580K	1.68%	3
2021 Q4	$1.31M	Buy	+23,338	New	+$1.21M	1.34%	5

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

Cook Wealth's GSK Position: Q2 2025 in Review

Cook Wealth sold out of GSK (GSK) in Q2 2025, closing a stake of 10,322 shares — an estimated $400K sold.

Cook Wealth first reported a position in GSK in Q4 2021 and held it in 14 quarters. The position peaked at $1.59M in Q1 2022. 891 funds tracked by Wall St. Rank hold GSK as of Q2 2025.

Cook Wealth reported no remaining GSK position as of Q2 2025 after selling out during the quarter.
Cook Wealth sold 10,322 GSK shares in Q2 2025, an estimated $400K.
Cook Wealth first reported a position in GSK in Q4 2021 and held it in 14 quarters.
Cook Wealth's GSK position peaked at $1.59M in Q1 2022.
891 funds tracked by Wall St. Rank held GSK as of Q2 2025.

Based on Cook Wealth's 13F filing for Q2 2025.